The expression of CXCR4 in colon cancer cells after treating with stromal cell-derived factor-1α (SDF-1α, or CXCL12) was investigated, along with the cancer cell proliferation rate and chemosensitivity to 5-FU, irinotecan, and oxaliplatin. The gene discussed is CXCL12; the disease is colonic neoplasm.